What Are SMZ-TMP Tablets?

Sulfamethoxazole and Trimethoprim tablets — commonly abbreviated as SMZ-TMP or TMP-SMX — are a double-strength potentiated sulfonamide antibiotic combination containing sulfamethoxazole 800mg and trimethoprim 160mg per tablet. This is the generic veterinary equivalent of Bactrim DS (Double Strength), one of the most widely used combination antibiotics in both human and veterinary medicine.

The tablets are scored and can be halved for dose adjustment. They are not FDA-approved for veterinary use, but are widely prescribed by veterinarians for dogs and cats as an accepted off-label practice, and are registered for use in humans, horses, cattle, and swine.

How SMZ-TMP Works — Sequential Folate Blockade

SMZ-TMP is one of the most elegant antibiotic combinations in veterinary medicine because its two components attack the same bacterial pathway at two different steps, creating a synergistic double blockade of folic acid synthesis:

  • Sulfamethoxazole is a sulfonamide that competitively inhibits dihydropteroate synthase — the enzyme bacteria use to incorporate PABA (para-aminobenzoic acid) into dihydrofolic acid. Without this step, bacteria cannot produce the precursor to folic acid.
  • Trimethoprim then blocks the next step: it inhibits dihydrofolate reductase (DHFR) — the enzyme that converts dihydrofolate into tetrahydrofolate (the active form of folic acid). Without tetrahydrofolate, bacteria cannot synthesise thymidine, purines, or certain amino acids, halting DNA replication and cell division.

By blocking two sequential steps in the same pathway, SMZ-TMP achieves bactericidal effects (actually kills bacteria) at concentrations that individually would only be bacteriostatic. This sequential blockade also makes resistance development significantly harder — a bacterium would need to develop two separate resistance mechanisms simultaneously.

Mammals obtain folate from their diet and are much less affected by this mechanism than bacteria, explaining the drug’s selective toxicity.

Indications — What SMZ-TMP Treats in Dogs and Cats

Primary Licensed Indications

  • Urinary tract infections (UTI) — including uncomplicated cystitis and ascending pyelonephritis caused by susceptible E. coli, Klebsiella, Enterobacter, and Staphylococcus species. One of the most common veterinary uses.
  • Respiratory tract infections — including pneumonia, bronchitis, and tracheobronchitis caused by susceptible organisms
  • Skin and soft tissue infections — pyoderma, wound infections, impetigo, furunculosis
  • Gastrointestinal infections — enteritis and diarrhoea caused by susceptible bacteria
  • Otitis media/externa (ear infections) — where susceptible gram-negative or gram-positive bacteria are involved

Important Off-Label / Additional Indications

  • Prostatitis (dogs) — SMZ-TMP achieves excellent prostatic tissue penetration, making it one of the preferred antibiotics for chronic bacterial prostatitis in male dogs
  • Nocardia infections — SMZ-TMP is the drug of choice for Nocardia species, which can cause cutaneous, pulmonary, or disseminated infections in immunocompromised animals
  • Coccidiosis (Isospora) — TMP-SMX is effective against Isospora coccidia in dogs and cats (30mg/kg once or twice daily for 5–10 days); useful when toltrazuril is unavailable
  • Toxoplasmosis (Toxoplasma gondii) — used in combination therapy for clinical toxoplasmosis in cats and dogs
  • Pneumocystis pneumonia (Pneumocystis carinii) — SMZ-TMP is the primary treatment for Pneumocystis pneumonia in immunocompromised dogs (particularly Miniature Dachshunds, Cavalier King Charles Spaniels)
  • CNS infections — TMP-SMX penetrates the blood-brain barrier reasonably well, making it useful for some CNS bacterial infections

SMZ-TMP is NOT effective against: anaerobic bacteria, viruses, fungi, or organisms that do not synthesise their own folic acid (e.g. Enterococcus species). It should not be used as empiric therapy for infections where enterococcal organisms are suspected.

Composition per Tablet

Strength Sulfamethoxazole (SMX) Trimethoprim (TMP) Ratio
Double Strength (DS) — this product 800mg 160mg 5:1
Single Strength (SS) 400mg 80mg 5:1

The 5:1 ratio of SMX to TMP achieves optimal synergistic bactericidal activity in vivo.

Dosage

The standard veterinary dose is 25–30 mg/kg of the combined SMZ-TMP per day, given either once daily or divided into two doses 12 hours apart. This equates to approximately 13mg per pound once daily or 6.5mg per pound twice daily.

Dog/Cat Weight Dose (once daily) Dose (twice daily) DS Tablet (800/160mg)
5 kg (11 lb) ~150mg combined ~75mg x 2 0.5 tablet daily
10 kg (22 lb) ~300mg combined ~150mg x 2 0.5 tablet twice daily
15 kg (33 lb) ~450mg combined ~225mg x 2 0.5–1 tablet daily
20 kg (44 lb) ~600mg combined ~300mg x 2 1 tablet daily
30 kg (66 lb) ~900mg combined ~450mg x 2 1 tablet twice daily
40 kg (88 lb) ~1200mg combined ~600mg x 2 1.5 tablets daily

Always use your veterinarian’s prescribed dose and duration. For coccidiosis, higher doses of 30mg/kg twice daily may be used. Duration is typically 5–10 days for most infections; prostatitis may require 4–6 weeks. Follow veterinary instructions precisely.

Administration

  • Give orally, with or without food. If vomiting occurs on an empty stomach, give with food or a small treat.
  • Tablets are scored — they can be halved for smaller dogs and cats.
  • Can be crushed and mixed with food if needed — however, do not crush tablets for cats. The bitter taste causes profuse hypersalivation (drooling) in cats. Give whole tablets or consult your vet for a compounded formulation.
  • Ensure access to fresh water at all times during treatment — adequate hydration prevents crystalluria (crystal formation in urine) which can cause urinary tract blockage, particularly in cats.
  • Give the full prescribed course even if your pet appears better — stopping early risks relapse and resistance.

Contraindications

  • Hypersensitivity to sulfonamides or trimethoprim
  • Pregnancy and lactation — sulfonamides are potentially teratogenic; avoid entirely during pregnancy
  • Severe liver disease — both drugs are hepatically metabolised
  • Severe kidney disease or urinary obstruction — risk of crystalluria and accumulation of drug metabolites
  • Pre-existing keratoconjunctivitis sicca (KCS / dry eye) — see below
  • Pre-existing thyroid disease
  • Blood dyscrasias (anaemia, thrombocytopenia, neutropenia)
  • Doberman Pinschers and Rottweilers: These breeds have a significantly higher incidence of severe immune-mediated sulfonamide reactions — including immune-mediated thrombocytopenia, polyarthritis, and skin reactions. Use of sulfonamides in these breeds should be approached with extreme caution or avoided. If used, monitor very closely from the first dose.

⚠️ Critical Long-Term Monitoring: Three Things to Watch in Dogs

1. Keratoconjunctivitis Sicca (KCS — Dry Eye)

This is the most clinically significant long-term concern with sulfonamide use in dogs. Sulfonamides — including SMZ-TMP — can damage the lacrimal (tear-producing) glands in dogs, leading to reduced tear production. This causes KCS, also known as dry eye — a painful condition characterised by sticky, mucoid eye discharge, redness, and in severe cases corneal ulceration and permanent vision damage.

KCS can occur within days to weeks of starting treatment in susceptible dogs. It may be reversible if the drug is stopped early, but can become permanent. For any course of SMZ-TMP lasting more than 5–7 days, your veterinarian should perform Schirmer Tear Tests (STT) at baseline and during treatment to monitor tear production. Report any eye discharge, squinting, or redness immediately.

2. Hypothyroidism

Prolonged sulfonamide use can suppress thyroid hormone synthesis by inhibiting iodination reactions. This can lead to clinical hypothyroidism, particularly with courses lasting several weeks. Baseline thyroid function testing (T4) and monitoring during prolonged treatment is recommended.

3. Complete Blood Count (CBC)

Sulfonamides can cause bone marrow suppression — primarily thrombocytopenia (low platelets) and neutropenia (low white blood cells). For courses lasting more than 2 weeks, a CBC should be performed at baseline and at intervals during therapy. Report any unusual bruising, bleeding, or lethargy immediately.

Drug Interactions

Drug Interaction Action
Cyclosporine SMZ-TMP reduces therapeutic efficacy of cyclosporine AND increases nephrotoxicity risk Avoid concurrent use; monitor if essential
Warfarin / anticoagulants SMZ-TMP inhibits warfarin metabolism, increasing anticoagulant effect and bleeding risk Monitor PT/INR closely; dose adjustment may be needed
Phenytoin SMZ-TMP inhibits hepatic metabolism, increasing phenytoin blood levels Monitor phenytoin levels; reduce dose if needed
Methotrexate Sulfonamides displace methotrexate from plasma proteins, increasing free drug concentration and toxicity risk Avoid concurrent use
Oral hypoglycaemics (sulphonylureas) Enhanced hypoglycaemic effect Monitor blood glucose closely
Diuretics (thiazides) Increased risk of thrombocytopenia Use with caution; monitor platelet count
Digoxin SMZ-TMP may increase digoxin serum levels Monitor digoxin levels
Antacids / kaolin-pectin Reduced GI absorption of sulfonamides Separate dosing by at least 2 hours

Side Effects

Dogs

  • Reduced appetite, vomiting, diarrhoea — most common; give with food to reduce GI signs
  • KCS (dry eye) — most serious; see monitoring section above
  • Hypothyroidism — with prolonged use; reversible on discontinuation
  • Immune-mediated reactions — especially in Dobermans and Rottweilers: skin rashes, fever, joint pain, thrombocytopenia. Can be severe and life-threatening.
  • Crystalluria — crystal formation in urine; ensure adequate water intake
  • Facial swelling, urticaria — signs of allergic reaction; discontinue immediately

Cats

  • Reduced appetite, hypersalivation — especially if tablets are crushed; give whole tablets to cats
  • GI signs — less common than in dogs
  • Cats with folate deficiency may be more sensitive to TMP-SMX effects

Storage

  • Store at room temperature (15–30°C / 59–86°F), away from moisture and heat
  • Keep in original packaging, away from children and pets
  • Do not use beyond the expiry date printed on the packaging

Frequently Asked Questions

Is this the same as Bactrim DS?

Yes — Sulfamethoxazole 800mg + Trimethoprim 160mg is the generic formulation of Bactrim DS (Double Strength). The active ingredients and concentrations are identical. Brand names like Bactrim DS, Septra DS, and Trisulfin are all the same drug combination at the same strength.

Can SMZ-TMP be used for a dog UTI?

Yes — UTIs are one of the primary indications for SMZ-TMP in dogs. It achieves high urinary concentrations and is effective against the most common uropathogens including E. coli, Klebsiella, and Staphylococcus. However, resistance rates in uropathogenic E. coli are rising in some areas — your vet may recommend a urine culture and sensitivity test before prescribing to confirm susceptibility.

Why does my dog need eye monitoring on SMZ-TMP?

Sulfonamides can damage tear gland tissue, reducing tear production and causing keratoconjunctivitis sicca (dry eye). This is a serious condition that can lead to corneal ulceration and permanent vision damage. For treatment courses beyond 5–7 days, Schirmer Tear Tests should be performed at baseline and regularly during treatment. Report any eye discharge, squinting, or cloudiness immediately.

How long does SMZ-TMP treatment last?

Duration depends on the infection being treated: uncomplicated UTIs or skin infections typically 5–10 days; respiratory infections 7–14 days; prostatitis 4–6 weeks; Nocardia infections may require months of treatment. Always complete the full course your veterinarian prescribes, even if your pet improves earlier.

Can I crush the tablet for my cat?

Not recommended. The bitter taste of SMZ-TMP causes intense hypersalivation (drooling) in cats when the tablet is crushed. Give whole tablets to cats, ideally wrapped in a small piece of food (avoiding dairy). If your cat refuses whole tablets, ask your vet about compounded liquid formulations of trimethoprim-sulfadiazine instead.

Is this safe for Doberman Pinschers?

Doberman Pinschers and Rottweilers are at significantly higher risk of serious immune-mediated adverse reactions to sulfonamides, including immune-mediated thrombocytopenia (low platelets causing bruising and bleeding), polyarthritis, and severe skin reactions. If a sulfonamide is prescribed for these breeds, monitor extremely closely from the first dose and report any bruising, bleeding, joint swelling, or skin changes immediately. Many veterinarians choose alternative antibiotics for these breeds where possible.

Related products: Veraflox 60mg Pradofloxacin Tablets for Dogs | Clavaseptin 250mg (Amoxicillin + Clavulanate) for Dogs | Veraflox Oral Suspension for Cats

Reviews

There are no reviews yet.

Be the first to review “Sulfamethoxazole & Trimethoprim Tablets (SMZ-TMP / Bactrim DS Generic) – Antibiotic for Dogs & Cats | 800mg/160mg”